FDA Approves Wearable Version of Sanofi’s Blood Cancer Drug Sarclisa
The U.S. Food and Drug Administration (FDA) has approved a wearable version of Sanofi’s blood cancer drug Sarclisa, marking the first FDA-approved cancer treatment that can be administered through an on-body injector attached to...